Improving GLP-1 analog quantitation through bioanalysis

GLP-1 receptor agonists have transformed the treatment of metabolic diseases, but their complex structure and pharmacokinetics necessitate powerful and sensitive analytical techniques.

Discussion points:

  • Key hurdles in quantifying GLP-1 analogs
  • Validation and design of LC-MS/MS methods
  • Considerations for sample preparation and matrices
  • Ensuring regulatory and bioanalytical compliance
  • Case studies and real-world applications

Learn more about SCIEX 7500+ system here >

Speaker:

Veena Roshan, Application Support Specialist, SCIEX

Veena is a scientist with expertise in analytical and instrumental analysis who has worked with SCIEX since 2018.

She has substantial experience with small-molecule quantitation procedures for compounds such as mycotoxins, pesticide residues, antibiotics, and n-nitrosamine impurities in various food matrices, as well as NDSRI quantification in pharmaceutical medicinal substances and products.

Other Webinars from SCIEX

Life Science Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.